MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | +20.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -28.6% | 2,500 | -48.2% | 0.00% | – |
| Q4 2019 | $7,000 | +40.0% | 4,830 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -83.9% | 4,830 | -63.7% | 0.00% | -100.0% |
| Q2 2019 | $31,000 | -20.5% | 13,300 | -24.9% | 0.00% | -25.0% |
| Q1 2019 | $39,000 | -9.3% | 17,700 | -27.8% | 0.00% | 0.0% |
| Q4 2018 | $43,000 | +230.8% | 24,500 | +600.0% | 0.00% | +300.0% |
| Q3 2018 | $13,000 | +30.0% | 3,500 | -48.5% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | -91.7% | 6,800 | -87.9% | 0.00% | -90.0% |
| Q1 2018 | $121,000 | +426.1% | 56,200 | +1024.0% | 0.01% | +900.0% |
| Q4 2017 | $23,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |